SCHEMBL589557

SCHEMBL589557

Oc1cc(-c2ccccc2)cc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.59
TRPM4 Q8TD43 1/20 0.56
KDM4E B2RXH2 2/20 0.52
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
MPI P34949 1/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B1 P14061 2/20 0.51
HSD17B2 P37059 2/20 0.51
ESR1 P03372 5/20 0.50
ESR2 Q92731 5/20 0.50
ALOX5 P09917 3/20 0.50
CYP1A2 P05177 1/20 0.48
HTR6 P50406 2/20 0.45
BACE1 P56817 1/20 0.44
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467361 1.00 NQO2 (0.59) NQO2TRPM4KDM4EMEN1ALDH1A1
SCHEMBL8196720 0.93 NQO2 (0.67) NQO2TRPM4KDM4EMEN1ALDH1A1
SCHEMBL312189 0.88 ESR1 (0.67) NQO2TRPM4HSD17B1HSD17B2ESR1
SCHEMBL15998719 0.84 NQO2 (0.52) NQO2TRPM4ALDH1A1HSD17B1HSD17B2
SCHEMBL7527606 0.84 NQO2 (0.52) NQO2TRPM4HSD17B1HSD17B2ESR1
SCHEMBL11883070 0.84 ALOX5 (0.52) NQO2TRPM4HSD17B1HSD17B2ESR1
SCHEMBL15998721 0.81 CA12 (0.53) NQO2TRPM4KDM4EMEN1ALDH1A1
SCHEMBL8172910 0.80 AKR1B1 (0.44) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL312277 0.80 SMN1; SMN2 (0.53) NQO2KDM4EMEN1ALDH1A1MAPT
SCHEMBL14417357 0.79 HSD17B1 (0.79) KDM4EHSD17B1HSD17B2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120058450-A C (sp) in benzene ring2) Method for deuteration of the H bond 云南大学 2025-05-30 CN claimed
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 US claimed
CN-101781179-B Method for preparing 1,2-naphthoquinone compound CHINA GATEWAY PHARMACEUTICAL DEV SHANGHAI CO LTD 2014-01-29 CN claimed
CN-101619016-B Method for synthesizing polysubstitution 3-phenyl-1-naphthol UNIV ZHEJIANG 2012-08-01 CN claimed
CN-101781179-A Method for preparing 1,2-naphthoquinone compound CHINA GATEWAY PHARMA PRODUCTS 2010-07-21 CN claimed
CN-101619016-A Method for synthesizing polysubstitution 3-phenyl-1-naphthol UNIV ZHEJIANG 2010-01-06 CN claimed
EP-4567515-A2 COMPOSITION COMPRISING NAPHTHOPYRAN PHOTOSWITCHABLE PHOTOINITIATORS AND THIOLS FOR LOCALLY POLYMERIZING A STARTING MATERIAL BY DUAL COLOR PHOTOPOLYMERIZATION Xolo GmbH (DE) 2025-06-11 EP disclosed
US-20250179222-A1 COMPOSITION COMPRISING NAPHTHOPYRAN PHOTOSWITCHABLE PHOTOINITIATORS AND THIOLS FOR LOCALLY POLYMERIZING A STARTING MATERIAL BY DUAL COLOR PHOTOPOLYMERIZATION XOLO GMBH (DE) 2025-06-05 US disclosed
CN-120058450-A C (sp) in benzene ring2) Method for deuteration of the H bond 云南大学 2025-05-30 CN disclosed
CN-119219550-A Reduction method of carboxylic ester compound 云南大学 2024-12-31 CN disclosed
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 US disclosed
EP-4208021-A1 PREPARATION OF NUCLEATED RBC (NRBC) ANALOGS FOR USE AS REFERENCE HEMATOLOGY CONTROLS IN AUTOMATED HEMATOLOGY ANALYZERS Bio-Rad Laboratories, Inc. (US) 2023-07-12 EP disclosed
CN-116097093-A Preparation of Nucleated RBC (NRBC) analogs for use as reference blood controls in automated blood analyzers 生物辐射实验室股份有限公司 2023-05-09 CN disclosed
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL LIMITED (IE) 2002-11-21 US disclosed
US-6478989-B1 Aromatic substituted naphthopyrans TRANSITIONS OPTICAL, INC. 2002-11-12 US disclosed
EP-1017690-B1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS PPG IND OHIO INC (US) 2001-12-05 EP disclosed
EP-1017690-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS PPG Industries Ohio, Inc. (US) 2000-07-12 EP disclosed
WO-1999015519-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS PPG INDUSTRIES OHIO, INC. (US) 1999-04-01 WO disclosed
US-4788204-A TRANQUILIZERS; ANTICONVULSANTS; ANGINA AND IMMUNODIFICIENCY TREATMENTS RHONE-POULENC SANTE (FR) 1988-11-29 US disclosed
US-4788199-A ANXIOLYTICS, ANTICONVULSANTS, ANTIANGINA AGENTS RHONE-POULENC SANTE (FR) 1988-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TYR, B3GNT2, PAH NQO2 304/4885TRPM4 2893/4885KDM4E 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.